Galectin-1 is involved in multiple metastatic processes: (1) adhesion of tumor cells to the ECM [77,94]; (2) binding of ECM glycoproteins [5,77]; and (3) enhancing proteolytic enzyme pathways [104,105]. This evidence concerns the gene LGALS1 and neoplasm.